Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$48.25 - $100.49 $4,825 - $10,049
-100 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$88.71 - $120.43 $1,774 - $2,408
-20 Reduced 16.67%
100 $10,000
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $372,227 - $524,763
-2,930 Reduced 96.07%
120 $18,000
Q4 2020

Feb 12, 2021

SELL
$99.96 - $135.93 $219,912 - $299,046
-2,200 Reduced 41.9%
3,050 $393,000
Q3 2020

Nov 12, 2020

SELL
$80.32 - $111.8 $84,336 - $117,390
-1,050 Reduced 16.67%
5,250 $587,000
Q2 2020

Aug 13, 2020

BUY
$60.49 - $97.5 $381,087 - $614,250
6,300 New
6,300 $511,000
Q1 2020

May 14, 2020

SELL
$59.04 - $88.81 $132,840 - $199,822
-2,250 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$59.49 - $82.78 $59,490 - $82,780
1,000 Added 80.0%
2,250 $176,000
Q3 2019

Nov 12, 2019

BUY
$62.59 - $110.3 $78,237 - $137,875
1,250 New
1,250 $80,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Monetary Management Group Inc Portfolio

Follow Monetary Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monetary Management Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monetary Management Group Inc with notifications on news.